Skip to main content
    S

    Sensus Healthcare Inc (SRTS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.34
    +0.02 (+0.65%)

    Market Cap: $38.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sensus Healthcare Inc (SRTS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sensus Healthcare (SRTS) trades at 2.3x sales and 1.1x book value. Its P/S of 2.3x is below its 5-year median of 2.5x. Its forward P/E is 21.4x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E21.4x
    Price to sales2.3x
    Price to book1.1x
    PEGN/A
    FCF yield-29.9%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 25.8% below 3.1x and its P/B is 59.3% below 2.7x.

    MultipleCurrent5-year median10-year median
    P/S2.3x2.5x3.1x
    P/B1.1x1.5x2.7x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 5.1x in 2022 to 78.7x in 2023.

    Year endPriceP/EP/SP/B
    2025$3.98N/A2.4x1.4x
    2024$6.9217.3x2.7x2.0x
    2023$2.3678.7x1.6x0.8x
    2022$7.425.1x2.8x2.6x
    2021$7.2230.1x4.4x4.6x
    2020$3.86N/A6.6x3.0x
    2019$3.54N/A2.1x2.0x
    2018$7.41N/A4.0x4.5x
    2017$5.16N/A3.3x5.9x
    2016$5.25N/A4.4x4.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SRTS

    What is SRTS's forward P/E ratio?

    Sensus Healthcare has a forward P/E ratio of 21.4x.

    Is SRTS stock overvalued?

    GNG's valuation label for SRTS is Undervalued.

    What is SRTS's price to sales ratio?

    Sensus Healthcare has a price to sales ratio of 2.3x.